Fenwal Inc FDA Record
- Latest inspection NAI · Aug 7, 2017
- 2 Class I recalls
- Last warning letter 2016
Fenwal Inc has 10 FDA recalls (2 Class I), 2 inspections, 3 510(k) clearances and 1 compliance action on record. FDA has issued 1 warning letter to Fenwal Inc, the most recent on Oct 14, 2016.
- Latest recall
- Z-1255-2023 · Class II · Feb 14, 2023
- Latest inspection
- Aug 7, 2017 · NAI
- Latest 510(k)
- Jun 10, 2014
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 10 (2 Class I) | Drug: Nov 20, 2026 (checked Nov 22, 2026, unchanged); Device: Nov 20, 2026 (checked Nov 22, 2026, unchanged); Food: Nov 22, 2026 | Drug: File dated Nov 19, 2026; Device: File dated Nov 19, 2026; Food: File dated Nov 19, 2026 | Current |
| 510(k) clearances | 3 | Nov 22, 2026 | File dated Nov 18, 2026 | Current |
| Inspections | 2 | Nov 22, 2026 | Newest record Nov 9, 2026 | Current |
| Compliance actions | 1 | Nov 22, 2026 | Newest record Nov 13, 2026 | Current |
FDA record by year
Fenwal Inc: FDA inspections per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 2 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 3 | 0 |
| 2020 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 0 | 0 | 0 | 4 | 2 |
| 2018 | 0 | 0 | 0 | 0 | 0 |
| 2017 | 1 | 0 | 0 | 0 | 0 |
Reviewing Fenwal Inc as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Fenwal Inc yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Fenwal Inc FDA Warning Letters
| Issued | Subject | Issuing office | Close-out letter |
|---|---|---|---|
| Oct 14, 2016 · Record page |
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| Z-1255-2023 | Class II | Amicus Exchange Kit Therapeutics. Component of Amicus Separator multiprocedural apheresis platform | Feb 14, 2023 |
| Z-1254-2023 | Class II | Amicus MNC Apheresis Kit Double Needle. Component of Amicus Separator multiprocedural apheresis… | Feb 14, 2023 |
| Z-1344-2021 | Class II | Amicus Exchange Kit - Product Usage: intended for use in the collection of blood components and… | Feb 25, 2021 |
| Z-1343-2021 | Class II | Amicus MNC Apheresis Kit - Double Needle - Product Usage: intended for use in the collection of… | Feb 25, 2021 |
| Z-1345-2021 | Class II | Amicus Exchange Kit Therapeutics - Product Usage: intended for use in the collection of blood… | Feb 25, 2021 |
| Z-2065-2019 | Class I | Vigilant Agilia, Vigilant Drug'Lib, REF Z073476, versions 1.0 and 1.1 Product Usage: Vigilant… | Jun 24, 2019 |
| Z-2064-2019 | Class I | VOLUMAT MC AGILIA US, Infusion Pump, REF Z021135, software versions 1.7 and 1.9a Product Usage… | Jun 24, 2019 |
| Z-1209-2019 | Class II | Fresenius Kabi CATSmart device (Continuous autotransfusion System). Labeled as the following kits… | Mar 5, 2019 |
| Z-1059-2019 | Class II | Vacuum Unit for CATSmart Vacuum Pump. Fresenius CATSmart (Continuous Autotransfusion System) is… | Feb 11, 2019 |
| Z-1523-2013 | Class II | AMICUS Exchange Kit; Product Usage: This kit is designed for use with the AMICUS separator for… | May 24, 2013 |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Aug 7, 2017 | Lake Zurich, IL | Devices | No Action Indicated (NAI) | 3004548776 |
| Mar 20, 2009 | Lake Zurich, IL | Devices | Voluntary Action Indicated (VAI) | 3004548776 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
Compliance Actions
FDA's compliance actions data lists 1 compliance action under Fenwal Inc: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3004548776 | Lake Zurich, IL | 2 | Aug 7, 2017 |
Recent 510(k) clearances
| K-Number | Device | Date |
|---|---|---|
| K141019 | AMICUS SEPARATOR SYSTEM/ AMICUS SEPERATOR SYSTEM;REFURBISHED | Jun 10, 2014 |
| K111702 | AMICUS SEPARATOR SYSTEM- USE IN THERAPEUTIC PLASMA EXCHANGE AND FILTER SET FOR AMICUS TPE | Mar 22, 2012 |
| K073339 | BLOOD COMPONENT RECIPIENT SET WITH STANDARD SIZE FILTER AND INFUSION SET WITH SIDE ARM LUER… | Mar 3, 2008 |
Fenwal Inc and the FDA: common questions
Has Fenwal Inc received an FDA warning letter?
Yes. FDA has issued 1 warning letter to Fenwal Inc. The most recent is dated Oct 14, 2016.
Has Fenwal Inc received an FDA Form 483?
FDA has not published a Form 483 for "Fenwal Inc" in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Fenwal Inc?
The most recent FDA inspection on file ended Aug 7, 2017 at Lake Zurich, IL and was classified NAI. FDA has 2 inspections of Fenwal Inc on file.
Has Fenwal Inc had an FDA recall?
Yes. Fenwal Inc has 10 FDA recalls on record, 2 of them Class I, the most serious class. The most recent started Feb 14, 2023.
Need more than this page shows? Ask about Fenwal Inc in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.